• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625358019
Device Problem High Test Results (2457)
Patient Problems Stroke/CVA (1770); Transient Ischemic Attack (2109); Insufficient Information (4580); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 05/10/2023
Event Type  Injury  
Manufacturer Narrative
During the time of the event, the patient allegedly used coaguchek xs meter serial number (b)(6) with test strip lot number 67192316 (expiration date = 31-jul-2024).The meter and strips were requested for investigation.A replacement product was sent.The product has not been received at this time and is not expected to be returned.If the product is returned in the future, a follow-up report will be submitted.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Product labeling states: "the coaguchek system uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas deviations can occur when compared to methods using other thromboplastins.However, those deviations between thromboplastins of different origin (e.G., rabbit based) are not specific to coaguchek products.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared to other laboratory methods." after the reported event, the customer reported result discrepancies with the same device and this is documented in the medwatch with mfg report number 1823260-2023-02269.Section e3: occupation is patient/consumer.
 
Event Description
It was alleged that a patient had temporary paralysis that occurred sometime between (b)(6) 2023 and (b)(6) 2023 due to a blood clot in the brain.It was reported there were no changes in the patient's anticoagulation treatment during this time period.The patient was allegedly diagnosed with ischemic stroke and was treated with an unknown medication.The patient allegedly could not use the left side of their body temporarily and it took a week to recover.It was reported that the patient had no permanent damage.The patient's therapeutic range is reported to be 2.5 - 3.0 inr.The patient has been reportedly using the device for 9 months and tests weekly.
 
Manufacturer Narrative
The health effect - clinical code has been updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK XS PT TEST
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key17357139
MDR Text Key319379403
Report Number1823260-2023-02362
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 08/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/20/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue Number04625358019
Device Lot Number67192316
Is the Reporter a Health Professional? No
Date Manufacturer Received07/27/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ASPIRIN (1X1).; BETASERC (3X1).; EFEXOR (1X1).; NOOTROPIL (3X1).; VITARIN.
Patient Outcome(s) Other;
Patient Age60 YR
Patient SexFemale
Patient Weight93 KG
-
-